Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Primary Peritoneal Carcinoma
Related studies linked through entity extraction aliases.
Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE1
Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE1
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
- Status
- COMPLETED
- Phase
- N/A
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
- Status
- RECRUITING
- Phase
- PHASE1
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
HIPEC After Initial CRS in Patients Who Have Received NACT
- Status
- UNKNOWN
- Phase
- PHASE1
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery
- Status
- UNKNOWN
- Phase
- PHASE3
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
BEACON - ABC in Recurrent Platinum Resistant HGSOC
- Status
- UNKNOWN
- Phase
- PHASE2
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anti-PD-L1 and SAbR for Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
- Status
- UNKNOWN
- Phase
- PHASE1
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
EDMONd - Elemental Diet in Bowel Obstruction
- Status
- UNKNOWN
- Phase
- NA
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
- Status
- UNKNOWN
- Phase
- NA
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
- Status
- UNKNOWN
- Phase
- N/A